Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
$l_{0}$ Norm Constraint LMS Algorithm for Sparse System Identification
- Y. Gu, J. Jin, Shunliang Mei
- Mathematics, Computer Science
- IEEE Signal Processing Letters
- 5 June 2009
TLDR
Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
- J. Duncan, Martin C. Whittle, +24 authors G. Johnson
- Biology, Medicine
- Cell
- 13 April 2012
Kinase inhibitors have limited success in cancer treatment because tumors circumvent their action. Using a quantitative proteomics approach, we assessed kinome activity in response to MEK inhibition… Expand
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells.
- M. Vedadi, D. Barsyte-Lovejoy, +29 authors J. Jin
- Biology, Medicine
- Nature chemical biology
- 1 August 2011
Protein lysine methyltransferases G9a and GLP modulate the transcriptional repression of a variety of genes via dimethylation of Lys9 on histone H3 (H3K9me2) as well as dimethylation of non-histone… Expand
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains.
- T. Stuhlmiller, Samantha M. Miller, +17 authors G. Johnson
- Biology, Medicine
- Cell reports
- 21 April 2015
Therapeutics that target ERBB2, such as lapatinib, often provide initial clinical benefit, but resistance frequently develops. Adaptive responses leading to lapatinib resistance involve reprogramming… Expand
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
- F. Liu, X. Chen, +17 authors J. Jin
- Chemistry, Medicine
- Journal of medicinal chemistry
- 24 December 2009
SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template led to the discovery of 8 (UNC0224) as a potent and selective G9a inhibitor. A high resolution X-ray crystal structure of the… Expand
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia.
Enhancer of zeste homolog 2 (EZH2) and related EZH1 control gene expression and promote tumorigenesis via methylating histone H3 at lysine 27 (H3K27). These methyltransferases are ideal therapeutic… Expand
Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons
- Hsien-Sung Huang, J. Allen, +12 authors B. Philpot
- Biology, Medicine
- Nature
- 29 November 2011
Angelman syndrome is a severe neurodevelopmental disorder caused by deletion or mutation of the maternal allele of the ubiquitin protein ligase E3A (UBE3A). In neurons, the paternal allele of UBE3A… Expand
A Stochastic Gradient Approach on Compressive Sensing Signal Reconstruction Based on Adaptive Filtering Framework
- J. Jin, Y. Gu, Shunliang Mei
- Mathematics, Computer Science
- IEEE Journal of Selected Topics in Signal…
- 22 February 2010
TLDR
The promise and peril of chemical probes.
- C. Arrowsmith, J. Audia, +51 authors W. Zuercher
- Computer Science, Medicine
- Nature chemical biology
- 21 July 2015
TLDR
Allosteric ligands for the pharmacologically dark receptors GPR68 and GPR65
- X. Huang, Joel Karpiak, +16 authors B. Roth
- Biology, Computer Science
- Nature
- 26 November 2015
TLDR